BioNexus Gene Lab Corp Common stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $76 | $22 | $483 | $2,543 |
Gross Profit | 12 | -22 | -3 | 377 |
EBITDA | -286 | -496 | -665 | |
EBIT | -540 | -708 | ||
Net Income | -286 | -543 | -1,036 | -708 |
Net Change In Cash | 76 | 22 | 483 | 2,543 |
Free Cash Flow | -443 | -148 | 960 | -1,238 |
Cash | 1,232 | 3,964 | 4,039 | 2,894 |
Basic Shares | 2,417 | 2,417 | 2,417 | 1,796 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $7,424 | $9,510 | $9,770 | $10,928 |
Gross Profit | 1,085 | 1,289 | 1,329 | 1,259 |
EBITDA | -2,796 | -1,420 | -2,485 | -185 |
EBIT | -2,965 | -1,573 | -2,593 | -291 |
Net Income | -2,984 | -1,598 | -2,629 | -355 |
Net Change In Cash | 7,424 | 9,510 | 9,770 | 10,928 |
Free Cash Flow | -1,875 | -2,461 | -1,910 | 489 |
Cash | 2,383 | 4,377 | 5,929 | 2,118 |
Basic Shares | 1,856 | 1,781 | 1,722 | 1,440 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.12 |
2026-03-31 | -$0.22 |
2025-12-31 | -$0.52 |
2025-09-30 | -$0.40 |